PHR peer analysis
Phreesia (PHR) against its competitors: price, today's move, 1-year return and market value side by side.
PHR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ESTA Establishment Labs | $70.74 | 1.77% | 7.49% | $2.11B |
| GDRX GoodRx | $3.38 | -2.59% | 20.70% | $1.17B |
| KMTS Kestra Medical | $28.30 | 0.11% | 13.86% | $1.70B |
| NEOG Neogen | $11.09 | 1.74% | 72.59% | $2.42B |
| NVCR NovoCure | $10.71 | -3.86% | -4.79% | $1.25B |
| OMCL Omnicell | $34.72 | 2.12% | 1.40% | $1.59B |
| OMDA Omada Health | $13.16 | -6.53% | -29.70% | $848.68M |
| SDGR Schrodinger | $27.16 | 5.85% | 54.98% | $2.03B |
| TDOC Teladoc Health | $8.06 | -5.06% | 21.19% | $1.49B |
| PHR Phreesia | $12.26 | -2.39% | -40.92% | $755.40M |
- PHR's peers: ESTA (Establishment Labs), GDRX (GoodRx), KMTS (Kestra Medical), NEOG (Neogen), NVCR (NovoCure), OMCL (Omnicell), OMDA (Omada Health), SDGR (Schrodinger).
Updated 2026-11-19 00:45 UTC